BVF INC/IL — Form 4 insider transactions

BVF INC/IL — Full 13F portfolio →

Buys and sells reported on SEC Form 4 — filed within two business days of each trade when a filer's ownership in a stock crosses 10%. This is the fastest public window into what the manager is doing.

Transaction date Activity Security Shares Price Total Filing
2026-07-14 Tender XOMA Royalty Corp 772,000 — — SEC filing
2026-07-14 Tender XOMA Royalty Corp 412,000 — — SEC filing
2026-07-14 Tender XOMA Royalty Corp 2,773,545 — — SEC filing
2026-07-14 Tender XOMA Royalty Corp 3,635,758 — — SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 51,858 $106.50 $5,522,877 SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 113,289 $106.50 $12,065,278 SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 627,597 $106.50 $66,839,080 SEC filing
2026-06-26 Sell Kymera Therapeutics, Inc. 837,914 $106.50 $89,237,841 SEC filing
2026-05-14 Conversion XOMA Royalty Corp 772,000 $4.03 $3,111,160 SEC filing
2026-05-14 Conversion XOMA Royalty Corp 412,000 $4.03 $1,660,360 SEC filing
2026-05-14 Conversion XOMA Royalty Corp 1,506,000 $4.03 $6,069,180 SEC filing
2026-05-14 Conversion XOMA Royalty Corp 2,313,000 $4.03 $9,321,390 SEC filing

How Form 4 differs from 13F

13F filings are quarterly snapshots, up to 45 days late. Form 4 is transaction-level and lands within two business days — but only covers stocks where the filer reports beneficial ownership above 10%. Pair the two: 13F for the whole portfolio, Form 4 for what the largest holders are doing right now.

All insider transactions →